Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
RELPAX® (eletriptan hydrobromide) Tablets
Medication labelWhy this: Advisory · dailymed-prescription
RELPAX is indicated for the acute treatment of migraine with or without aura in adults. RELPAX is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Safety and effectiveness of RELPAX Tablets have not been established for cluster headache, which is present in an older, predominantly male population.
- generic_name
- eletriptan hydrobromide
- product_names
- eletriptan hydrobromide
- ndc
- 16590-201, 0049-2340, 16590-201-06
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en